Delivery Order SPE2DB22D2214-SPE2DB25FS6DX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Fluticasone Propionate 50 micrograms nasal spray in a 16-gram formulation. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,030.32 and is scheduled for completion by August 15, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fluticasone Propionate 50 micrograms nasal spray in 16-gram units. This firm fixed-price delivery order, valued at $2,347.96, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was made through open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fluticasone Propionate 50 microgram nasal spray in 16-gram units, with a ceiling value of $1,754.80 and a firm fixed price structure. This non-set-aside delivery order is scheduled for ultimate completion by August 8, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award is classified as a child contract,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Fluticasone Propionate 50 micrograms nasal spray in 16-gram units. This firm fixed price contract, valued at $1,465.32, represents a non-competitive delivery order with an ultimate completion date of July 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and serves as a child order under a larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,442.40 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 microgram nasal spray in 16-gram units. This firm fixed-price delivery order, issued on July 24, 2025, represents a competitive award with no set-aside designation and is scheduled for ultimate completion by July 25, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Fluticasone Propionate 50 micrograms nasal spray in 16-gram units, with a ceiling value of $1,716.74. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Fluticasone Propionate 50 mcg nasal spray in 16-gram quantities. This firm fixed-price delivery order, valued at $1,308.96, represents a non-competitive set-aside contract and is scheduled for completion by August 6, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,606.19 on August 15, 2025, for Fluticasone Propionate 50 microgram nasal spray in 16-gram units. The contract carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be completed by August 18, 2025, with the product to be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Fluticasone Propionate 50 mcg nasal spray in 16-gram containers. This is a firm fixed-price delivery order with a ceiling value of $1,357.14, representing a non-set-aside competitive award with an ultimate completion date of August 1, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $1,232.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms nasal spray (16 grams) on July 18, 2025, with an ultimate completion date of July 21, 2025. This contract was not designated under any set-aside program and represents a competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6DXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Fluticasone Propionate 50 microgram nasal spray in 16-gram units, with a ceiling value of $1,502.23 and a firm fixed price structure. The order is scheduled for completion by August 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through the DLA's Medical Supply Chain. The company fulfills a diverse portfolio of pharmaceutical products and medical supplies supporting military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. This award reflects the company's ongoing role in supporting defense health requirements through the DLA's Pharmaceutical Prime Vendor program, which ensures reliable access to essential medications and medical supplies for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/15/25 |